Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)

Merck Sharp & Dohme LLC · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
squamous-cell-carcinoma
head and neck squamous cell cancer, squamous cell carcinoma, head and neck carcinoma, programmed cell death-1 (pd1, pd-1),, programmed death-ligand 1 (pdl1, pd-l1), programmed cell death receptor ligand 2 (pdl2, pd-l2), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 870636
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.